HCP
GMAB icon

Hexagon Capital Partners’s Genmab GMAB Stock Holding History

Hexagon Capital Partners’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-635
Closed -$12.4K – 725
2025
Q1 		$12.4K Sell
635
-73
-10% -$1.53K ﹤0.01% 907
2024
Q4 		$14.8K Buy
708
+421
+147% +$9.25K ﹤0.01% 896
2024
Q3 		$7K Sell
287
-33
-10% -$882 ﹤0.01% 997
2024
Q2 		$8.04K Buy
320
+1
+0.3% +$28 ﹤0.01% 930
2024
Q1 		$9.54K Hold
319
– – ﹤0.01% 865
2023
Q4 		$10.2K Sell
319
-31
-9% -$973 ﹤0.01% 823
2023
Q3 		$12.3K Sell
350
-23
-6% -$876 ﹤0.01% 684
2023
Q2 		$14.2K Sell
373
-16
-4% -$638 ﹤0.01% 661
2023
Q1 		$14.7K Sell
389
-52
-12% -$2K ﹤0.01% 634
2022
Q4 		$18.7K Sell
441
-217
-33% -$8.94K 0.01% 562
2022
Q3 		$21K Sell
658
-46
-7% -$1.61K 0.01% 580
2022
Q2 		$23K Buy
704
+46
+7% +$1.49K 0.01% 507
2022
Q1 		$24K Hold
658
– – 0.01% 482
2021
Q4 		$26K Hold
658
– – 0.01% 465
2021
Q3 		$29K Hold
658
– – 0.01% 417
2021
Q2 		$27K Hold
658
– – 0.01% 408
2021
Q1 		$21K Hold
658
– – 0.01% 420
2020
Q4 		$26K Hold
658
– – 0.01% 353
2020
Q3 		$22K Buy
+658
New +$23.8K 0.01% 343

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Hexagon Capital Partners's GMAB Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Genmab (GMAB) in Q2 2025, closing a stake of 635 shares — an estimated $12.4K sold.

Hexagon Capital Partners first reported a position in GMAB in Q3 2020 and held it in 19 quarters. The position peaked at $29K in Q3 2021. 217 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 635 Genmab shares in Q2 2025, an estimated $12.4K.
  • Hexagon Capital Partners first reported a position in Genmab in Q3 2020 and held it in 19 quarters.
  • Hexagon Capital Partners's Genmab position peaked at $29K in Q3 2021.
  • 217 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.